Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

Tricyclazole

Generic Name: Tricyclazole

Drug Type: Small Molecule

Chemical Formula: C_₉H_₇N_₃S

CAS Number: 41814-78-2

Unique Ingredient Identifier: R7U3MEU7VR

Overview

No overview information available.

Background

No background information available.

Indication

No indication information available.

Associated Conditions

No associated conditions information available.

Clinical Trials

Zanubrutinib Combined With BEAM for ASCT in Relapsed and Refractory DLBCL

Phase 2

Not yet recruiting

Posted: 2024/10/22

Sponsor:Ruijin Hospital

ID:NCT06652165

Selinexor Combined With BEAM for ASCT in R/R DLBCL With MYC Positive

Phase 2

Not yet recruiting

Posted: 2024/10/22

Sponsor:Ruijin Hospital

ID:NCT06652139

A Randomized Clinical Trial Comparing Chi-BEAM With BEAM Regimen Combined With ASCT for the Treatment of ND PTCL

Phase 3

Recruiting

Posted: 2023/07/05

Sponsor:The First Affiliated...

ID:NCT05931263

Modified BEAM Regimen for T Cell Lymphoma Underwent ASCT

Not Applicable

Not yet recruiting

Posted: 2023/04/18

Sponsor:First Affiliated Hos...

ID:NCT05814718

BeEAM Versus CEM in Lymphoma Patients as a Conditioning Regimen Before Autologous Hematopoietic Cell Transplantation

Not Applicable

Completed

Posted: 2023/04/14

Sponsor:

Rehab Werida

ID:NCT05813132

FDA Approved Products

No FDA products found for this drug

Singapore Approved Products

No Singapore products found for this drug

Related News

No news found

Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

Home Terms & Conditions Privacy Policy